ALPS Medical Breakthroughs ETF (SBIO)

ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund in the Health category. It has $211.56M in assets, an expense ratio of 0.50% and a 0.00% dividend yield. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.